AR096310A1 - 3,4-DIHYDROISOQUINOLIN-2 (1H) -ILO COMPOUNDS - Google Patents

3,4-DIHYDROISOQUINOLIN-2 (1H) -ILO COMPOUNDS

Info

Publication number
AR096310A1
AR096310A1 ARP140101951A ARP140101951A AR096310A1 AR 096310 A1 AR096310 A1 AR 096310A1 AR P140101951 A ARP140101951 A AR P140101951A AR P140101951 A ARP140101951 A AR P140101951A AR 096310 A1 AR096310 A1 AR 096310A1
Authority
AR
Argentina
Prior art keywords
compounds
dihydroisoquinolin
halogen
formula
ilo
Prior art date
Application number
ARP140101951A
Other languages
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR096310A1 publication Critical patent/AR096310A1/en

Links

Abstract

La presente se refiere a ciertos compuestos de 3,4-dihidroisoquinolin-2(1H)-ilo, particularmente compuestos de fórmula (1), y composiciones farmacéuticas de los mismos. La presente además proporciona métodos para usar un compuesto de fórmula (1) para tratar el deterioro cognitivo asociado con la enfermedad de Parkinson o esquizofrenia. Reivindicación 1: Un compuesto de la fórmula (1) caracterizado porque n es 0, 1 ó 2; R¹ es halógeno; R² es halógeno, H, CN, alcoxi C₁₋₃ o alquilo C₁₋₃; y R³ es H, halógeno, alcoxi C₁₋₃ o alquilo C₁₋₃.This refers to certain 3,4-dihydroisoquinolin-2 (1H) -yl compounds, particularly compounds of formula (1), and pharmaceutical compositions thereof. The present further provides methods for using a compound of formula (1) to treat cognitive impairment associated with Parkinson's disease or schizophrenia. Claim 1: A compound of the formula (1) characterized in that n is 0, 1 or 2; R¹ is halogen; R² is halogen, H, CN, C₁₋₃ alkoxy or C₁₋₃ alkyl; and R³ is H, halogen, C₁₋₃ alkoxy or C₁₋₃ alkyl.

ARP140101951A 2013-05-30 2014-05-15 3,4-DIHYDROISOQUINOLIN-2 (1H) -ILO COMPOUNDS AR096310A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361828740P 2013-05-30 2013-05-30

Publications (1)

Publication Number Publication Date
AR096310A1 true AR096310A1 (en) 2015-12-23

Family

ID=56120452

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140101951A AR096310A1 (en) 2013-05-30 2014-05-15 3,4-DIHYDROISOQUINOLIN-2 (1H) -ILO COMPOUNDS

Country Status (2)

Country Link
AR (1) AR096310A1 (en)
MA (1) MA38636A1 (en)

Also Published As

Publication number Publication date
MA38636A1 (en) 2017-09-29

Similar Documents

Publication Publication Date Title
DOP2015000289A (en) 3,4-DIHYDROISOQUINOLIN-2 (1H) -ILO COMPOUNDS
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
PH12015502502A1 (en) Heteroaromatic compounds and their use as dopamine d1 ligands
MX2015011273A (en) Use of pyrazolopyrimidine derivatives for the treatment of pi3kî´ related disorders.
CR20160523A (en) IMIDAZO COMPOUNDS [4,5-C] QUINOLIN-2-ONA AND ITS USE TO TREAT CANCER
CR20200276A (en) SULFAMOYLARYLAMIDES AND THEIR USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B (DIVISIONAL EXP. 2015-0059)
BR112014017021A2 (en) irak inhibitors and uses thereof
EA201400338A1 (en) DERIVATIVES OF AMINOPYRIMIDINE FOR USING AS KINASE ACTIVITY MODULATORS
EA201491747A1 (en) SUBSTITUTED PYRIDOPYRIMIDINE COMPOUNDS AND THEIR APPLICATION AS FLT3 INHIBITORS
MA38982A1 (en) Novel octahydro-cyclobuta [1,2-c; 3,4-c '] dipyrrol-2-yl
EA201491610A1 (en) MODULATORS X LIVER RECEPTORS
CL2013003056A1 (en) Compounds derived from (phenyl or pyridin) -ethynyl- (pyridin or pyrimidin) substituted; pharmaceutical composition comprising them; process of preparing this; and its use in the treatment of schizophrenia or cognitive diseases.
GT201400242A (en) "NEW COMPOUNDS OF PIRAZOL"
EA201691831A1 (en) HETEROAROMATIC COMPOUNDS AND THEIR APPLICATION AS DOPAMINE D1 LIGANDS
PH12016501993A1 (en) Heteroaromatic compounds and their use as dopamine d1 ligands
PH12016500735A1 (en) Substituted pyrimidine compounds and their use as syk inhibitors
EA201600002A1 (en) DERIVATIVES OF SUBSTITUTED TRIAZOLOPIRIDINES
AR096310A1 (en) 3,4-DIHYDROISOQUINOLIN-2 (1H) -ILO COMPOUNDS
BR112016028081A2 (en) NEW COMPOUNDS AS ANTITUBERCULAR AGENTS

Legal Events

Date Code Title Description
FG Grant, registration